Pazopanib medication regimen

Pazopanib(Pazopanib) is an oral anticancer drug used to treat renal cell carcinoma and soft tissue sarcoma. It belongs to a class of drugs called multi-target tyrosine kinase inhibitors. The course of medication is usually determined by the doctor based on the patient's specific situation and condition. It is recommended that patients follow the doctor's advice and use it as directed on the prescription. The recommended dose of pazopanib is 800 mg once a day, taken at least 1 hour before or 2 hours after meals. Patients benefit from it and the side effects are controllable, and the treatment can be continued. This drug is only available with a prescription. During the medication, the doctor may require regular examinations and monitoring to ensure the efficacy and safety of the drug.